Hypertension jab is just five years away

American Heart Association Conference HRT may be cardioprotective, promising results for hypertension jab, disturbed sleep link to statin and ARBs 'best choice in chronic kidney disease'.

An injection to control hypertension could be available within five to 10 years, Swiss scientists have claimed.

Preliminary findings indicate that an antibody vaccine, that binds to angiotensin II so it is unable to activate angiotensin receptors, has efficacy and is tolerable. It is the first vaccine shown to reduce BP, according to the researchers.

The study included 72 people with mild-to-moderate hypertension who were injected with 100(mu)g or 300(mu)g of the vaccine CYT006-AngQb, or placebo.

Injections of the vaccine developed by company Cytos Biotechnology in Zurich were given at baseline, and at four and 12 weeks later.

Patients given the vaccine showed a strong response against angiotensin II, especially when given the stronger dose, researchers told delegates at the American Heart Association scientific sessions in Orlando, Florida.

Evaluation of 24-hour BP at 14 weeks showed those given 300(mu)g of vaccine had a 5.6mmHg reduction in systolic BP and a 2.8mmHg reduction in diastolic BP.

These effects were more pronounced between 5am and 8am, when hypertensive patients are at most risk of MI, said lead researcher Professor Juerg Nussberger, from the University Hospital of the Canton of Vaud in Lausanne, Switzerland.

rachel.liddle@haymarket.com

AHA scientific sessions 4-7 November 2007, Orlando, Florida

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

First COVID-19 jabs to target care home residents and staff under new JCVI advice

First COVID-19 jabs to target care home residents and staff under new JCVI advice

Older adults living in care homes and staff working there will be first to receive...

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...